Back to search results

Virtual Reality for Attention in Neurodivergent Children

This study is exploring if a virtual reality (VR) game called "Electrical Maze" can help neurodivergent children improve their attention. It's for children aged 9 to 18 who have autism, ADHD (Attention Deficit Hyperactivity Disorder), specific learning disorder, or developmental coordination disorder. Participants will play the VR game twice a week for 25 minutes per session, over 6 weeks. Researchers will use tests like the RightEye Assessment and the Test of Variables of Attention (TOVA) to see if the game helps children pay attention for longer periods. The current recruitment status is unclear.

Study design
This study plans to enroll 40 participants in a quasi-experimental design. It is an interventional study, but the phase is not specified.
What's involved
You would participate in two 25-minute VR sessions per week for 6 weeks. You would also complete attention assessments like the RightEye and TOVA.
Compensation
Not stated in the trial record.
Follow-up
Assessments like the RightEye and TOVA are measured at individual test times, but the duration of follow-up after the 6-week intervention is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07341204

How Virtual Reality Can Help Neurodivergent Children Improve Their Attention

Not Yet Recruiting
NAAges 9–18InterventionalTreatment
New York Institute of Technology
~40 participants
Updated 2026-01-14 on ClinicalTrials.gov
What's tested:Virtual Reality

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
RightEye Assessment:
Measured over Individual tests: 60 seconds (e.g., saccades) to 4-5 minutes (e.g., reaction time or pursuit tasks). Total session: 15-20 minutes, including 1-2 minutes for 9-point calibration and setup.
+1 more outcome measured

Conditions

Autism
Autism Disorder
ADHD - Attention Deficit Disorder With Hyperactivity
Attention Deficit Disorder

Explore related trials

Attention Deficit Hyperactivity DisorderAutism Spectrum DisorderDevelopmental Coordination DisorderSpecific Learning Disorder

NCT07341204

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Inclusive Sports and Fitness, Inc.

    Old Westbury, New Yorkstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Alexander Lopez, JD, OT/L
[email protected]
16312525776
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Clinical diagnosis of ASD, ADHD, SLD, or DCD confirmed by a licensed clinician or documented in medical/educational records (DSM-5 or equivalent).
Parent/guardian consent and participant assent (age-appropriate).
Ability to follow simple verbal instructions and to participate in 25-minute VR sessions twice weekly for 6 weeks.
Stable medication regimen for attention- or behavior-related medications for ≥4 weeks prior to baseline (or not taking such medications).
Visual and auditory ability adequate for VR tasks (with or without usual corrective lenses/hearing aids).
Availability to attend all scheduled sessions at the clinical site across the 6-week period.

Exclusion

History of photosensitive epilepsy or any uncontrolled seizure disorder.
Severe intellectual disability or severe communication impairment that prevents understanding/participation (e.g., non-responsive to simple commands required by the VR tasks).
Severe visual, auditory, or motor impairment that prevents safe or functional use of the VR system (e.g., inability to hold controllers or view the headset even with correction).
Recent (within 6 months) significant brain injury or neurosurgery. Significant history of motion sickness, severe vestibular disorder, or prior intolerance to immersive VR.
Any medical or implanted device contraindicated for VR/headset use (if applicable).

What this trial measures

  • RightEye Assessment:Individual tests: 60 seconds (e.g., saccades) to 4-5 minutes (e.g., reaction time or pursuit tasks). Total session: 15-20 minutes, including 1-2 minutes for 9-point calibration and setup.

    The RightEye system uses an infrared camera-based sensor bar attached to a monitor to objectively measure and analyze eye movements in real-time. It quantifies changes in attention-related oculomotor functions, including saccadic accuracy, smooth pursuit, reaction time, distractibility, and sustained attention. These metrics provide objective biomarkers for inattention and impulsivity, supporting occupational therapy goals of enhancing visual-motor integration, executive function, and participation in daily activities like reading or classroom engagement.

  • Test of Variables of Attention (TOVA)Standard visual test: 21.6 minutes (4 quarters of 5.4 minutes). Full session: 30-45 minutes (setup/review); short form for younger children (10.8 minutes; used for ages 9+).

    The TOVA objectively measures sustained attention and inhibitory control via responses to visual stimuli (targets vs. non-targets). In this study, the visual TOVA will assess pre- and post-VR changes in attention in children with neurodevelopmental conditions, targeting omission errors, commission errors, response time, and response time variability.